Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This research highlights the essential role of skin findings in diagnosing and managing rheumatic diseases, emphasizing their importance in early recognition, classification, and treatment planning, which requires collaboration between rheumatologists and dermatologists.

This chapter reviews skin manifestations in common rheumatic diseases, particularly those with polyarthritis, and offers a differential diagnosis of erythema nodosum without presenting new research findings.

This study found that specific skin lesions are common indicators of pediatric rheumatologic diseases, potentially aiding dermatologists and rheumatologists in diagnosis when biopsies are challenging.

This article reviews how normal pregnancy changes can mimic rheumatologic disorders, emphasizing the importance of distinguishing these from true autoimmune inflammation, but reports no new evidence.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

This article reviews the prevalence, causes, and associated conditions of hidradenitis suppurativa, a chronic inflammatory skin disease, but reports no new clinical findings.

The authors concluded that sexual dysfunction is highly prevalent yet often overlooked in patients with autoimmune rheumatic disease, and they emphasize the need for increased awareness, research, and integration into clinical practice.

This article reviews how skin manifestations can aid in diagnosing various systemic diseases, focusing primarily on their association with rheumatologic conditions while also addressing vascular, granulomatous, and other disease impacts, aiming to provide dermatologists with practical diagnostic insights.

This article discusses the interaction between menopause and rheumatic diseases, emphasizing the need for rheumatologists to recognize menopausal symptoms and consider hormone replacement therapy in patient care, but it provides no new experimental results.

This article discusses the classification and significance of cutaneous manifestations in systemic lupus erythematosus, emphasizing the importance of recognizing these skin features for disease management, but reports no new clinical results.

This study found that skin diagnoses in rheumatology patients were often unrelated to their underlying rheumatologic diseases, highlighting the importance of collaboration between dermatologists and rheumatologists.

This case report describes an 8-year-old girl with Mixed Connective Tissue Disease who experienced remission after treatment with immunomodulator drugs, highlighting the diagnostic value of anti-U1 RNP antibody testing in children.

This review discusses the development of Janus kinase inhibitors for dermatologic diseases and reports no new results; the authors note the need for further research on their efficacy and safety.

This guideline outlines the management of systemic lupus erythematosus in adults but reports no new clinical findings.

In this case report, a 45-year-old woman with systemic lupus erythematosus underwent a six-month integrative naturopathic and yoga program while continuing conventional treatment, aiming to document improvements in disease management and patient well-being.

This review details common symptoms of rheumatic diseases and how to differentiate them from other conditions based on patient history and physical examination.

This review explores hair signs related to nutrition disorders, such as thin and dyspigmented hair, without presenting new clinical findings; the authors highlight unknowns regarding underlying causes.

This study found that among mixed connective tissue disease patients in a tertiary care hospital in Pakistan, Raynaud phenomenon was the most common clinical feature, present in 80% of patients.

The study reported a 7.80% prevalence of scarring alopecia in Chinese SLE patients and identified several risk factors, including mucocutaneous lesions and high disease activity, while renal and cardio-respiratory involvements were negatively associated with it.

In this study, among patients taking hydroxychloroquine for dermatologic or rheumatologic conditions, none developed symptoms suggestive of SARS-CoV-2 infection despite Italy's high infection rate at the time.

This review discusses the dermatological adverse events from immunosuppressive and anti-TNF therapy in IBD, finding increased risks of non-melanoma skin cancer and other skin conditions, and recommends regular cancer screening.

This study found that patients with rheumatoid arthritis, atopic dermatitis, and alopecia areata receiving baricitinib had low incidence rates of adverse events, especially among low-risk individuals, with varying rates among those at higher risk.

This study reports that improvement with corticosteroids or other immunosuppressants in Satoyoshi syndrome suggests an autoimmune origin, supported by its association with other autoimmune diseases and autoantibodies.

This study found that 59.7% of lupus patients self-reported alopecia, which was linked to anti-Ro antibody presence and cutaneous SLE symptoms but not to age, ethnicity, or medication.

This study reports a case of constrictive pericarditis associated with COVID-19, highlighting the need for imaging, biomarkers, and histology for effective evaluation and treatment decisions.

This review examines clinical data on the efficacy and safety of JAK inhibitors used for immune-mediated conditions beyond rheumatoid arthritis, highlighting their potential therapeutic roles in various inflammatory diseases.

This narrative review discusses the role and importance of rheumatologists in managing autoimmune interstitial lung disease and emphasizes the need for enhanced collaboration with respiratory physicians to improve diagnosis, management, and outcomes; no new clinical results are reported.

This article reviews the complexity and diverse manifestations of systemic lupus erythematosus, highlighting potential genetic, hormonal, and environmental factors in its pathogenesis without presenting new clinical findings.

This article reviews systemic lupus erythematosus (SLE) and highlights the FDA approval of belimumab, marking the first new SLE treatment in nearly 50 years, but reports no new clinical trial results.

This article reviews the spectrum of connective tissue disorders and discusses the role of autoantibodies, particularly in lupus erythematosus, but reports no new findings.